Progenitor cells in auricular cartilage demonstrate cartilage-forming capacity in 3D hydrogel culture by Ilyas, Khan
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in:
European Cells and Materials
                                         
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa41044
_____________________________________________________________
 
Paper:
Otto, I., Levato, R.,  Webb, W., Khan, I., Breugem, C. & Malda, J. (2018).  Progenitor cells in auricular cartilage
demonstrate cartilage-forming capacity in 3D hydrogel culture. European Cells and Materials, 35, 132-150.
http://dx.doi.org/10.22203/eCM.v035a10
 
 
 
 
 
 
This article is distributed in accordance with Creative Commons Attribution Licence.
 
_____________________________________________________________
  
This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms
of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior
permission for personal research or study, educational or non-commercial purposes only. The copyright for any work
remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium
without the formal permission of the copyright holder.
 
Permission for multiple reproductions should be obtained from the original author.
 
Authors are personally responsible for adhering to copyright and publisher restrictions when uploading content to the
repository.
 
http://www.swansea.ac.uk/library/researchsupport/ris-support/ 
 132 www.ecmjournal.org
IA Otto et al.                                                                                Auricular progenitors for cartilage tissue engineering
Abstract
Paramount for the generation of auricular structures of clinically-relevant size is the acquisition of a large 
number of cells maintaining an elastic cartilage phenotype, which is the key in producing a tissue capable of 
withstanding forces subjected to the auricle. Current regenerative medicine strategies utilize chondrocytes 
from various locations or mesenchymal stromal cells (MSCs). However, the quality of neo-tissues resulting 
from these cell types is inadequate due to inefficient chondrogenic differentiation and endochondral 
ossification, respectively. Recently, a subpopulation of stem/progenitor cells has been identified within 
the auricular cartilage tissue, with similarities to MSCs in terms of proliferative capacity and cell surface 
biomarkers, but their potential for tissue engineering has not yet been explored. This study compared the in 
vitro cartilage-forming ability of equine auricular cartilage progenitor cells (AuCPCs), bone marrow-derived 
MSCs and auricular chondrocytes in gelatin methacryloyl (gelMA)-based hydrogels over a period of 56 d, 
by assessing their ability to undergo chondrogenic differentiation. Neocartilage formation was assessed 
through gene expression profiling, compression testing, biochemical composition and histology. Similar to 
MSCs and chondrocytes, AuCPCs displayed a marked ability to generate cartilaginous matrix, although, 
under the applied culture conditions, MSCs outperformed both cartilage-derived cell types in terms of matrix 
production and mechanical properties. AuCPCs demonstrated upregulated mRNA expression of elastin, low 
expression of collagen type X and similar levels of proteoglycan production and mechanical properties as 
compared to chondrocytes. These results underscored the AuCPCs’ tissue-specific differentiation potential, 
making them an interesting cell source for the next generation of elastic cartilage tissue-engineered constructs.
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Introduction
A significant challenge in cartilage tissue engineering 
is the recruitment of a sufficient number of cells for 
the generation of large tissue constructs (Bichara 
et al., 2012). The necessity for larger constructs is 
exemplified by the case of auricular reconstruction 
required for the congenital disorder microtia and for 
defects of the auricle caused by injury and disease. 
For the human auricle, estimates of the number of 
cells required for tissue regeneration range between 
100 and 150 million (Bichara et al., 2012), with the 
obvious challenge of obtaining this number of cells 
from an autologous source.
 Although considerable progress has been made 
using a variety of cells for auricular cartilage tissue 
engineering, there is no definitive conclusion on 
which cell type is capable of providing the most 
favorable clinical outcome for tissue-engineered 
cartilage constructs. Originating from the native 
tissue, chondrocytes are a logical cell source for the 
generation of neocartilage. Auricular (Bichara et 
al., 2014; Cao et al., 1997; García-López et al., 2015; 
Isogai et al., 2006; Kusuhara et al., 2008; Nakao et 
al., 2017; Papadopoulos et al., 2011; Park et al., 2004; 
Pomerantseva et al., 2016; Reiffel et al., 2012; Sanz et 
al., 2007; Tseng et al., 2014; Xu et al., 2005), microtia 
(Ishak et al., 2015; Kamil et al., 2004b; Nakao et al., 
2017), nasoseptal (Ávila et al., 2015; Bichara et al., 
2010; Haisch et al., 2002; Isogai et al., 2006; Kusuhara 
et al., 2008), costal (Isogai et al., 2006; Kusuhara et al., 
2008) and articular chondrocytes (Isogai et al., 2006; 
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Kamil et al., 2004a; Kusuhara et al., 2008; Mizuno 
et al., 2014) are all used for tissue-engineering 
auricular cartilage. Specific characteristics and 
ability for chondrogenesis can differ depending on 
the origin of the chondrocytes. Where the articular 
and costal cartilage are of mesenchymal origin, the 
developmental origin of the auricular cartilage of 
the pinna is still controversial. The auricle originates 
from two pharyngeal arches that have contributions 
from all three embryonic layers (Wright, 1997; 
Graham, 2001; Luquetti et al., 2011; Tracy et al., 2013). 
Nevertheless, fully differentiated cells from various 
cartilage origins generally demonstrate the capacity 
to produce cartilage-like extracellular matrix in 
vitro and in vivo (Ahmed and Hincke, 2014; Bichara 
et al., 2010; Isogai et al., 2006; Kusuhara et al., 2008; 
Pleumeekers et al., 2013). However, only a small 
amount of tissue can be harvested from the patient, 
requiring extensive in vitro expansion of the isolated 
cells to obtain a sufficient cell’s number for the 
production of clinically-relevant tissue-engineered 
cartilage constructs. The proliferative potential of 
chondrocytes is naturally low (Phull et al., 2016) and 
their cartilage-forming ability is known to decline 
with extended cultivation (Homicz et al., 2002; 
Schnabel et al., 2002). In fact, repeated passaging of 
chondrocytes induces the loss of their chondrogenic 
phenotype (Saadeh et al., 1999) and, ultimately, leads 
to progressive dedifferentiation. To some extent, 
re-differentiation can be attained under specific 
culture conditions, e.g. in three-dimensional (3D) 
environments (Benya and Shaffer, 1982) and in the 
presence of appropriate growth factors (Jakob et al., 
2001; van Osch et al., 2001), yet the revenue is limited 
(van Osch et al., 2001). The resulting neo-tissue is 
often of a fibrocartilagenous quality and exhibits 
inferior biochemical and mechanical properties 
as compared to native cartilage tissue (Chung et 
al., 2006; Demoor et al., 2014; Nabzdyk et al., 2009; 
Williams et al., 2010). In the past decade, stem cells 
have gained increasing interest for tissue engineering 
applications because of their capacity for self-renewal 
and multilineage differentiation. For example, bone-
marrow-derived mesenchymal stromal cells (MSCs) 
can be extensively expanded (Gardner et al., 2013) and 
demonstrate the ability to differentiate into various 
cell types, including chondrocytes, osteoblasts and 
adipocytes (Pittenger et al., 1999). Numerous studies 
have successfully used MSCs for the generation of 
cartilage (Cheng et al., 2014; Seda Tigli et al., 2009; 
Vinardell et al., 2012), sometimes in co-culture with 
auricular chondrocytes (Liu et al., 2010; Pleumeekers 
et al., 2015; Zhao et al., 2016). Nevertheless, the risk 
of hypertrophic growth, terminal differentiation and 
subsequent tissue calcification remains an important 
limitation when using MSCs for cartilage tissue 
engineering (Williams et al., 2010; Gawlitta et al., 
2010). In addition, bone marrow-derived MSCs are 
not involved in the development of native auricular 
cartilage and are, as articular, costal and nasoseptal 
chondrocytes, not predisposed to produce the 
elastic fibers required for this elastic-type cartilage 
(Kusuhara et al., 2008).
 Tissue-derived stem/progenitor cells exhibit 
stem-cell-like qualities, such as self-renewal and 
multipotency, yet are embedded within the target 
tissue in niches and are primed to differentiate to that 
tissue (Jayasuriya and Chen, 2015). The identification 
of resident progenitor cell populations in articular 
cartilage (Dowthwaite et al., 2004; Williams et al., 2010) 
as well as in auricular and tracheal perichondrium 
(Derks et al., 2013; Kobayashi et al., 2011b; Togo et 
al., 2006) has opened up new pathways for cartilage 
tissue engineering. Like MSCs, which can undergo 
up to 70 population doublings (Christodoulou et 
al., 2013), cartilage progenitor/stem cells retain 
proliferative ability for up to 60 population doublings 
(Williams et al., 2010), demonstrating potential for 
accumulating large cell numbers starting from a 
single cell. In addition, the cells maintain multipotent 
differentiation ability while expressing chondrocyte-
specific characteristics (McCarthy et al., 2012). It is 
hypothesized that these tissue-specific progenitor 
cells are highly primed to differentiating into the 
chondrogenic lineage (Jayasuriya and Chen, 2015; 
McCarthy et al., 2012).
 Auricular cartilage tissue engineering may benefit 
greatly from a source of tissue-specific cells that can 
be expanded up to large numbers without losing their 
differentiation potential. Nevertheless, the auricular 
cartilage itself was, until recently, unknown to harbor 
a progenitor cell population. The presence of colony-
forming, multipotent progenitor cells in auricular 
cartilage has recently been confirmed (Xue et al., 
2016), though these cells have not yet been explored 
for a tissue-engineering purpose. The objective of the 
current study was to evaluate the cartilage-forming 
ability of such auricular cartilage progenitor cells in 
a 3D hydrogel culture. It was hypothesized that these 
cells, despite in vitro expansion, could outperform 
auricular chondrocytes and bone-marrow-derived 
MSCs with regards to production of auricular 
cartilage.
 Mimicking the hydrated environment of native 
cartilage, hydrogels are particularly attractive for 
cartilage regenerative strategies. Gelatin methacryloyl 
(gelMA)-based hydrogels are a versatile group of 
biomaterials shown to facilitate cartilage-like matrix 
production for chondrocytes, articular cartilage 
progenitor cells as well as MSCs, supporting both 
cell viability and mechanical properties (Levato et al., 
2017; Daly et al., 2016; Gao et al., 2015; Schuurman et 
al., 2013). In this study, cell-laden gelMA hydrogels 
were cultured for up to 8 weeks in chondrogenic 
differentiation media and harvested at day 1, 28 
and 56 for mechanical testing, biochemistry, gene 
expression, histology and immunohistochemistry 
for the assessment of cartilage-specific properties.
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Material and Methods
Isolation of cells
Primary auricular chondrocytes (AuCHs) and 
auricular cartilage progenitor cells (AuCPCs) were 
obtained from deceased equine donors, which were 
kindly provided by a local slaughterhouse. Bone-
marrow-derived MSCs were obtained from healthy 
equine donors. All tissues and cells were obtained 
according to the guidelines of the Institutional 
Animal Ethical Committee (the Netherlands).
 AuCHs and AuCPCs were harvested from the 
auricles of fresh equine cadavers (3- to 10-year-old; 
n = 3). The ears were cut off at the base, shaved, 
thoroughly washed with soap and soaked for circa 
15 min in Betadine® (Meda Pharma, Amstelveen, the 
Netherlands). Under sterile conditions, an incision 
through the skin was made on the dorsal side along 
the longitudinal axis and the skin and subcutaneous 
tissue were dissected. Ensuring the harvest of 
auricular cartilage exclusively, the perichondrium 
was fully removed by carefully scraping the 
tissue off with surgical tools. Cartilage chips were 
sectioned off the scapha of the ear, washed in sterile 
phosphate-buffered saline (PBS) and, subsequently, 
minced into 1 mm2 pieces. The tissue was digested 
in 0.2 % pronase (Roche) for 2 h followed by a 16 h 
0.075 % collagenase type II (Worthington Chemical 
Corporation, Lakewood, NJ, USA) digestion at 37 °C. 
Next, the solution was filtered through a 70 μm cell 
strainer and centrifuged for 5 min at 300 ×g to obtain 
a cell pellet. AuCHs were washed in sterile PBS, 
counted with a hemocytometer and stored at passage 
0 in liquid nitrogen until further use.
 For each donor, an aliquot of the freshly-isolated 
cells was saved for the isolation of AuCPCs, for which 
the cells were subjected to a fibronectin adhesion 
assay as previously described (Dowthwaite et al., 
2004; Williams et al., 2010). Briefly, cells suspended 
in serum-free Dulbecco’s modified Eagle medium 
(DMEM; 31966, Gibco) were plated at a density of 
500 cells/cm2 on fibronectin-coated tissue culture 
plates. After 20 min of incubation at 37 °C, the non-
adherent cells were carefully removed. Attached 
progenitor cells were cultured in chondroprogenitor 
expansion media, consisting of DMEM supplemented 
with 10 % v/v fetal bovine serum (FBS; Lonza), 
0.2 mM L-ascorbic acid 2-phosphate (Sigma-Aldrich), 
100 U/mL penicillin (Life Technologies), 100 μg/mL 
streptomycin (Life Technologies) and 5 ng/mL basic 
fibroblast growth factor (bFGF; Peprotech, London, 
UK). After 6 d of culture, colonies consisting of 
> 32 cells were harvested. Monoclonal colonies were 
pooled and expanded until passage 3, when they 
were stored in liquid nitrogen until further use.
 MSCs were obtained from bone marrow aspirates 
from the sternum of healthy equine donors (3- to 
10-year-old; n = 3) and the mononuclear fraction 
was isolated following a previously described 
protocol using a Ficoll®-Paque density gradient (GE 
Healthcare) (Visser et al., 2014). After isolation, MSCs 
were cultured in MSC expansion medium, consisting 
of alpha modification minimum essential medium 
(αMEM) (22561, Gibco) supplemented with 0.2 mM 
L-ascorbic acid 2-phosphate (Sigma-Aldrich), 10 % 
FBS (Lonza), 100 U/mL penicillin (Life Technologies), 
100 μg/mL streptomycin (Life Technologies) and 
1 ng/mL bFGF (Peprotech) until passage 3 and 
subsequently stored in liquid nitrogen until further 
use.
Characterization of equine auricular 
chondroprogenitor cells
AuCHs (at passage 1), AuCPCs and MSCs (both at 
passage 3) were characterized by comparison of gene 
expression of cell surface markers and assessment 
of multilineage differentiation potential in two 
dimensional (2D) culture.
 The expression of cell membrane markers was 
evaluated in duplicate by a reverse transcriptase-
polymerase chain reaction (RT-PCR), comparing 
the transcriptome of AuCHs, AuCPCs and MSCs. 
Analyzed target genes included CD13, CD29, CD31, 
CD34, CD44, CD45, CD49d, CD73, CD90, CD105, 
CD106, CD146 and CD166 (primer sequences and 
expected amplicon sizes are reported in Table 1), which 
were compared to expression of the housekeeping 
gene hypoxanthine phosphoribosyltransferase 
(HPRT1). RNA was isolated using the RNAeasy 
mini kit (Qiagen), according to the manufacturer’s 
instructions. Isolated mRNA was quantified by 
UV-vis spectrophotometry with a Nanodrop 
2000 (Thermo Scientific) to serve as template for 
polymerase chain reaction (PCR). The amplification 
of RNA was carried out using a SuperScript® One-
Step RT-PCR System with Platinum® Taq DNA 
Polymerase (Life Technologies) and the PCR products 
were run on agarose gel stained with ethidium 
bromide. Subsequently, the amplicons were imaged 
using a UV transilluminator (ProXima 10 Phi; Isogen 
Life Sciences, De Meern, the Netherlands).
 Multipotency was evaluated in duplicate through 
an in vitro trilineage differentiation assay in which 
cells were directed towards bone, fat or cartilage 
by culturing them in osteogenic, adipogenic or 
chondrogenic differentiation media, respectively. 
For osteogenic and adipogenic differentiation, cells 
were plated in 6-well culture plates at a density of 
2 × 105 cells/well and cultured in chondroprogenitor 
expansion medium until sub-confluency, before 
initiating differentiation. Osteogenic differentiation 
medium consisted of αMEM (Gibco) supplemented 
with 10 % v/v FBS (Lonza), 100 U/mL penicillin 
(Life Technologies), 100 μg/mL streptomycin (Life 
Technologies), 0.2 mM L-ascorbic acid 2-phosphate 
(Sigma-Aldrich), 20 mM β-glycerol phosphate 
(Sigma-Aldrich) and 100 nM dexamethasone 
(Sigma-Aldrich). Adipogenic medium consisted of 
αMEM (Gibco) supplemented with 10 % v/v FBS 
(Lonza), 100 U/mL penicillin (Life Technologies), 
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100 μg/mL streptomycin (Life Technologies), 
0.01 mM Indomethacin (Sigma-Aldrich), 83 mM 
3-Isobutyl-1-metylxanthine (Sigma-Aldrich) and 
1.72 μm bovine pancreas-derived insulin (Sigma-
Aldrich). Culture medium was refreshed every 3 d. 
For chondrogenic differentiation, 2.5 × 105 cells were 
pelleted by centrifugation at 300 ×g in 15 mL Falcon® 
tubes. Subsequently, the pellets were cultured in 
chondrogenic differentiation medium, consisting 
of DMEM supplemented with 1 % v/v insulin-
transferrin-selenous acid (ITS+ Premix; Corning), 
0.2 mM L-ascorbic acid 2-phosphate (Sigma-Aldrich), 
100 U/mL penicillin (Life Technologies), 100 μg/
mL streptomycin (Life Technologies), 100 nM 
dexamethasone (Sigma-Aldrich) and 10 ng/mL 
transforming growth factor β1 (TGF-β1; Peprotech). 
After 14 d of culture, osteogenic commitment was 
evaluated by alizarin red S staining to observe 
calcified matrix deposition, whereas adipogenic 
differentiation was assessed with oil red O staining 
to visualize the formation of intracellular lipid 
vesicles. Cell pellets were embedded in paraffin and 
5 μm-thick sections were stained with safranin O to 
visualize glycosaminoglycans (GAGs), indicative of 
chondrogenic differentiation.
Fabrication of cell-laden hydrogel constructs for 
3D culture
Following a previously published protocol (Melchels 
et al., 2014), the hydrogel gelatin methacryloyl 
(gelMA) was synthesized by functionalizing gelatin 
type A (obtained from porcine skin; Sigma-Aldrich) 
in PBS with methacrylic anhydride groups, to obtain 
a hydrogel with a 80 % degree of functionalization. 
Subsequently, a 10 % w/v solution of gelMA was 
supplemented with 0.1% w/v 2-hydroxy-1-[4-(2-
hydroxyethoxy)phenyl]-2-methyl-1-propanone 
(Irgacure 2959; BASF, Ludwigshafen, Germany) as a 
photoinitiator. AuCHs, AuCPCs or MSCs, expanded 
beforehand until passage 1, 4 and 4, respectively, 
were homogeneously suspended in the hydrogel 
at 37 °C at a concentration of 1.5 × 107 cells/mL. The 
cell-laden gel was immediately casted into a custom-
made Teflon™ mold to produce cylindrical samples 
(diameter = 6 mm, height = 2 mm) and subsequently 
chemically crosslinked by UV irradiation for 5 min 
(wavelength λ = 365 nm, intensity E = 3 mW/cm2, 
at a height of 2 cm; 144 portable UV lamp, Vilber 
Lourmat, Eberhardzell, Germany), to trigger free-
radical polymerization. Cell-free hydrogel samples 
(3 replicates per time point) were used as controls 
Target gene Primer sequence (5’ to 3’) Amplicon size (bp)
HPRT1 Fw: CAAGCTTGCTGGTGAAAAG 95
Rv: GGCATATCCTACGACAAACT
CD13 Fw: CTGAGTGGAGAGACAGAGTA 147
Rv: CTGGAAATACTCGAAGAGGG
CD29 Fw: CTGGAGATGGGAAACTTGG 229
Rv: GTTCCTACTGCTGACTTAGG
CD31 Fw: CAGAATCCTTCTCTATGCCC 194
Rv: CATGGCCATCACTGAGTAG
CD34 Fw: GACTCAAGGTATCTGCCTG 104
Rv: CCTGTTCTTTCTCACAGAGG
CD44 Fw: CTGGGGACTCTGCCTC 99
Rv: TAGCGGCCATTTTTCTCC
CD45 Fw: TTGAACGGCCTTGAACC 153
Rv: CTTGGCACCTTCAGTACC
CD49d Fw: CTACAACTTGGACACCGAG 201
Rv: GTCCGGTCTGGATTCTTTC
CD73 Fw: TCCGGACTTTATTTGCCG 346
Rv: CAGAGGTGACTATGAATGGG
CD90 Fw: CTCTACACATGCGAACTCC 90
Rv: CTCGCACTTGACCAGTTT
CD105 Fw: CAGTAATGAGGTGGTCGTC 108
Rv: CTGAGGTAGAGGCCCAG
CD106 Fw: ACTCTTACTTGTGCACGG 103
Rv: CCACTGAAACTGATCTCTGG
CD146 Fw: TCCGTGTGTACAAAGCTC 137
Rv: GTACCAGATGACCTGAGGA
CD166 Fw: GTCTTCTGCCTCTTGATCG 223
Rv: CTGTCTTTGTACTCTGGGAC
Table 1. RT-PCR forward (Fw) and reverse (Rv) primers sequences used for characterization of AuCH, 
AuCPC and MSC.
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and were prepared following the same steps. All 
hydrogel samples were cultured in chondrogenic 
differentiation medium for 1, 28 and 56 d at 37 °C and 
5 % CO2, refreshing media 3 times per week.
Gene expression of cartilage markers after 
chondrogenic differentiation
The relative gene expression of cartilage markers in 
cell-laden hydrogels (n = 3) was evaluated by qPCR 
at 1 and 56 d of culture. Analyzed markers included 
aggrecan (ACAN), cartilage oligomeric matrix 
protein (COMP), collagen type II (COL2A2), collagen 
type I (COL1A1), collagen type X (COLXA1), runt-
related transcription factor 2 (RUNX2) and elastin. 
The expression levels were normalized against the 
housekeeping gene HPRT1. Primer sequences for 
each transcript are reported in Table 2.
 Gel samples were mechanically ground in RLT 
buffer (Qiagen). From the lysate, mRNA was isolated 
using the RNeasy Mini Kit (Qiagen) and subsequently 
quantified with a Nanodrop 2000 (Thermo Scientific). 
A SuperScript® III Platinum SYBR Green One-Step 
qRT-PCR Kit (Life Technologies) was used for 
amplification of the mRNA and cDNA synthesis, 
which was performed with a LightCycler® 96 (Roche). 
The PCRminer algorithm (Zhao and Fernald, 2005) 
was used to calculate relative gene expression, Ct and 
efficiency values.
Biochemical analysis of cell-laden hydrogels
After 1, 28 and 56 d in culture, 4-6 replicates of 
each group of cell-laden hydrogels were taken for 
quantification of DNA and GAG content. Cell-
laden hydrogel samples were frozen at −20 °C and 
subsequently lyophilized. The wet and dry weights 
were recorded during this process. Digestion of 
samples occurred overnight at 60 °C in 200 μL 
papain digestion buffer (P3125; Sigma Aldrich), 
consisting of 0.2 M NaH2PO4 (Merck) and 0.01 
M ethylenediaminetetraacetic acid (EDTA; VWR) in 
milliQ water (pH = 6.0) supplemented with 250 μL/
mL papain solution (16-40 units/mg of protein) and 
0.01 M cysteine (C9768; Sigma Aldrich).
 Total DNA content was quantified using a Quant-
iT PicoGreen dsDNA assay (Life Technologies) and 
compared to a standard of known concentrations 
of DNA. The fluorescence was measured at 
485 nm excitation and 520 nm emission by a 
spectrofluorometer (Bio-Rad).
 Total GAG content, as a measure of cartilage-
specific matrix production, was quantified using a 
dimethylmethyleneblue (DMMB; pH = 3.0) assay. The 
525/595 nm absorbance ratio was measured with a 
VersaMax plate reader (Molecular Devices, Winnersh, 
UK). The sulfated GAG (sGAG) content was 
calculated using a standard of known concentrations 
of chondroitin sulfate C and corrected for the dilution 
factor.
 Both dsDNA and sGAG content were normalized 
against dry weight. The ratio of GAGs per DNA was 
calculated to display the activity of single cells in 
producing cartilage-specific matrix.
Compressive mechanical testing of hydrogel 
constructs
An unconfined uniaxial compression test was 
performed to evaluate the mechanical properties 
of the cell-laden hydrogel samples after 1, 28 and 
56 d in culture (4-6 replicates per time point). 
Using a dynamic mechanical analyzer (DMA Q800; 
TA Instruments, Asse, Belgium), samples were 
compressed at a –20 %/min strain rate to –30 %. 
Young’s modulus was calculated as the slope of the 
initial linear segment (10-15 % strain) of the stress/
strain curve.
Table 2. qPCR forward (Fw) and reverse (Rv) primers sequences used for evaluation of cartilage-like 
tissue synthesis.
Target 
gene Full name Primer sequence (5’ to 3’)
Amplicon size 
(bp)
HPRT1 Hypoxanthine phosphoribotransferase 1
Fw: AAGCTTGCTGGTGAAAAG 95
Rv: GCATATCCTACGACAAACT
ACAN Aggrecan Fw: AAGACAGGGTCTCGCTGCCCAA 115
Rv: ATGCCGTGCATCACCTCGCA
COL1A1 Collagen type I, α1 chain Fw: CGTGACCTCAAGATGTGC 94
Rv: AGAAGACCTTGATGGCGT
COL2A1 Collagen type II, α1 chain Fw: GGCAATAGCAGGTTCACGTACA 79
Rv: CGATAACAGTCTTGCCCCACTT
COL10A1 Collagen type X, α1 chain Fw: GGGAAACGGGATATGGTGCT 168
Rv: GTCCCCTTTCTCCCGGAATG
COMP Cartilage oligomeric protein Fw: CCACGTGAATACGGTCACAG 104
Rv: ACGTCTGCTCCATCTGCTTC
RUNX2 Runt-related transcription factor 2
Fw: GCAAGGTTCAACGATCTGA
248
Rv: GGGACACCTACTCTCATACT
ELASTIN Elastin Fw: TGGAGTCCCAGGTGTTGTTG 137
Rv: CATAGCCAGGAACCCCGAA
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Histology and immunohistochemistry
Deposition of the main components of cartilage 
extracellular matrix in cell-laden hydrogels were 
visualized by histology and immunohistochemistry 
on formalin-fixed, paraffin-embedded samples.
 After 1, 28 and 56 d in culture, samples from 
each group were fixated in 4 % neutral-buffered 
formalin. Then, they were dehydrated through a 
graded ethanol series (70 %, 96 % and 100 % ethanol), 
cleared in xylene and embedded in paraffin. The 
samples were sectioned into 5 μm-thick slices and 
deparaffinized prior to staining. For the identification 
of cartilage glycosaminoglycan deposition, a triple 
stain, consisting of hematoxylin (cell nuclei), fast 
green (collagens) and safranin O (proteoglycans), 
was applied. Deposition of collagens was evaluated 
by immunohistochemistry, with appropriate primary 
antibodies for collagen type II (II-II6B3; DSHB, Iowa 
City, IA, USA), collagen type I (sc-8784; Santa Cruz 
Biotechnology) and collagen type VI (5C6; DSHB). 
In addition, appropriate IgG were used as isotype 
controls. After deparaffinization, samples were 
treated with 0.3 % v/v H2O2 to block endogenous 
peroxidases. Antigen retrieval was performed 
with 1 mg/mL pronase (Roche) and 10 mg/mL 
hyaluronidase (H2126; Sigma-Aldrich), both applied 
for 30 min at 37 °C. Subsequently, tissue sections were 
blocked with bovine serum albumin (BSA, 5 % w/v 
in PBS) for 1 h at room temperature. The primary 
antibodies were incubated overnight at 4 °C, followed 
by a HRP-tagged secondary antibody for 1 h at room 
temperature, after which the staining was developed 
with 3,3-diaminobenzidine-horseradish peroxidase 
(Sigma-Aldrich). Cell nuclei were counterstained 
with hematoxylin. A von Kossa staining was applied 
to detect calcium precipitates indicating tissue 
mineralization. All stained sections were mounted 
in DPX mounting media (Millipore) and examined 
using a light microscope (Olympus BX51; Olympus).
Statistical analysis
Quantitative results are expressed as mean 
± standard error of the mean (SEM). The means of 
the experimental groups were compared at different 
time points by performing a two-way ANOVA with 
a Bonferroni post-hoc test. The statistical analyses 
were performed using Graphpad Prism 7 (Graphpad 
software). A value of p < 0.05 was considered 
statistically significant.
Results
Equine auricular cartilage progenitor cells 
displayed stem cell qualities
Histological evaluation confirmed that the 
perichondrial layer attached to auricular cartilage 
was successfully removed and, therefore, it was 
assumed that a population of exclusively cartilage-
derived cells was obtained after tissue digestion, 
prior to isolation of cartilage progenitor cells using 
differential adhesion to fibronectin (Fig. 1).
 Gene expression of several surface markers was 
analyzed for isolated AuCHs, AuCPCs and MSCs by 
RT-PCR (Fig. 2a), demonstrating that the transcript 
profile of AuCPCs shared similarities with both 
AuCHs and MSCs. Like MSCs, AuCPCs were positive 
for the stem cell markers CD73, CD90 and CD105 and 
negative for the hematopoietic marker CD34 and for 
the leukocyte marker CD45. Thus, at the transcript 
level, AuCPCs satisfied the minimal requirements 
to be classified as human MSCs (Dominici et al., 
2006). Furthermore, all three cell types were CD29+, 
CD31+, CD106+ and CD166+. Differences among cell 
types arose in the expression of CD13, CD49d and 
CD146. CD13 was highly positive in AuCPCs, to a 
lesser extent in MSCs and negative in AuCHs. CD49d 
appeared positive in MSCs and AuCPCs and negative 
in AuCHs. Lastly, CD146 was faintly positive in both 
MSCs and AuCPCs and negative in AuCHs.
 Multipotency of AuCPCs was assessed through 
a trilineage differentiation assay. Like MSCs (Fig. 
2c,e,f), AuCPCs demonstrated to be capable of 
differentiating towards bone (Fig. 2b), adipose tissue 
(Fig. 2d) and cartilage (Fig. 2f), confirming their 
multipotent potential.
Differential mRNA expression of cartilage 
markers in hydrogel culture
As measured by qPCR, AuCHs, AuCPCs and MSCs 
embedded in 3D hydrogels exhibited increased 
relative-fold expression levels of cartilage-specific 
Fig. 1. Safranin O staining 
(a) before and (b) after 
utilizing the scraping 
method for the removal 
o f  p e r i c h o n d r i u m , 
confirming its complete 
r e m o va l  f r o m  t h e 
auricular cartilage. Scale 
bars: 200 μm.
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gene transcripts over time, confirming their 
differentiation in the hydrogel (Fig. 3).
 After 56 d of culture, aggrecan expression (Fig. 
3a) was highest in AuCHs (48.8-fold upregulation), 
followed by AuCPCs (37.7-fold) and MSCs (15.7-fold). 
The same correlation was already apparent at day 
1: mRNA expression of aggrecan was significantly 
more upregulated in AuCHs and AuCPCs (10.8- and 
8.6-fold, respectively) than MSCs, expressing a 0.1-
fold reduction. The expression of aggrecan increased 
over time in all three cell types, yet this increase was 
significant only in AuCHs.
 A similar pattern was observed for the mRNA 
expression of COMP (Fig. 3b), which is a prominent 
non-collagenous matrix protein present in cartilage 
(Hedbom et al., 1992; DiCesare et al., 1995; Newton 
et al., 1994). After 56 d of culture, AuCPCs exhibited 
a significantly higher expression level of COMP 
than MSCs (186.2-fold versus 64.2-fold, respectively), 
with AuCHs displaying a 146.7-fold increment. 
Likewise, AuCPCs already demonstrated the highest 
upregulation of COMP (39.1-fold) at day 1, followed 
by AuCHs (20.5-fold) and MSCs (0.9-fold). Both 
AuCHs and AuCPCs displayed a significant increase 
in expression levels over time, whereas MSCs did not.
 After 56 d of culture, AuCHs and AuCPCs 
expressed COL2A1 (Fig. 3c) at comparable levels, 
with a 51- and 60-fold increment, respectively. MSCs 
exhibited the highest levels of COL2A1 mRNA with 
an 89.1-fold increment at day 56, yet this difference 
was not significant. Expression of COL2A1 was 
considerably lower (< 3.5-fold) in all three cell 
types at the beginning of the culture, indicating a 
significant increase over time in the case of AuCPCs 
and MSCs. Conversely, COL1A1 (Fig. 3d) was 
already highly upregulated at the beginning of the 
culture in MSCs (59.9-fold increment), compared 
to a significantly lower 19.3-fold in AuCHs and 
22.8-fold in AuCPCs. This trend reversed during 
chondrogenic differentiation, as in AuCHs, the 
expression of COL1A1 significantly increased 
over time. Differences among cell types were not 
significant at day 56, yet the highest expression at 
day 56 was measured in AuCHs (77.2-fold increment), 
followed by equivalent levels in AuCPCs and MSCs 
(54.2- and 48.1-fold, respectively). AuCHs exhibited 
significantly higher levels of COL10A1 at the end of 
culture (3-fold) in comparison to both AuCPCs and 
MSCs, which exhibited a 0.4-fold lesser expression 
(Fig. 3e). Both AuCHs and MSCs showed increasing 
yet non-significant levels of COL10A1, whereas, in 
AuCPCs, COL10A1 expression levels decreased non-
significantly over time.
 At day 56, the expression of RUNX2 (Fig. 3f), the 
master transcription factor during osteogenesis and 
endochondral ossification, was significantly higher in 
Fig. 2. Characterization of AuCPCs in comparison to AuCHs and MSCs. (a) The expression of several surface 
markers, analyzed by RT-PCR, was compared amongst the three cell types. Trilineage differentiation 
of AuCPCs and MSCs: (b,c) alizarin red staining demonstrating osteogenic differentiation, (d,e) oil 
red O staining demonstrating adipogenic differentiation and (f,g) safranin O staining demonstrating 
chondrogenic differentiation. Scale bars: 100 μm.
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MSCs (2.5-fold) as compared to AuCHs (0.3-fold) and 
AuCPCs (0.0-fold). At the start of the culture, RUNX2 
was upregulated by 1.1-fold in AuCHs, by 1.9-fold in 
AuCPCs and by 2.1-fold in MSCs. AuCPCs showed a 
significant decrease in RUNX2 expression over time 
to virtually zero at day 56.
 The critical structural component of elastic 
cartilage is elastin. AuCHs exhibited higher mRNA 
expression levels of elastin (1.4-fold at day 1 and 
2.6-fold at day 56) than MSCs (0.1-fold at day 1 and 
0.4-fold at day 56). Although not significant, AuCPCs 
showed the highest upregulation of elastin, with 
Fig. 3. Relative gene expression of (a) collagen type II, (b)collagen type I, (c) collagen type X, (d) aggrecan, 
(e) cartilage oligomeric matrix protein, (f) RUNX2 and (g) elastin, as obtained from qPCR analysis of 
cell-laden hydrogels. Statistically significant differences of p < 0.05 for comparisons between cell types 
are marked with *. For each cell type, statistically significant differences of p < 0.05 are marked with ᵃ for 
a significant difference to day 1 and ᵇ for a significant difference to day 56. 
140 www.ecmjournal.org
IA Otto et al.                                                                                Auricular progenitors for cartilage tissue engineering
4.4-fold and 3.9-fold increments at day 1 and 56, 
respectively (Fig. 3g).
Chondrogenic differentiation in hydrogels 
resulted in cartilage-specific matrix deposition
Cell proliferation and extracellular matrix deposition 
in cell-laden hydrogels was assessed by quantification 
of dsDNA and sGAG content, representative of cell 
number and proteoglycan quantity, respectively. 
As indicated by the increase in dsDNA content in 
the first 28 d of culture, AuCPCs and MSCs showed 
an ability to proliferate in the 3D gelMA hydrogel 
environment. The dsDNA content of AuCHs was 
significantly higher than AuCPCs and MSCs in the 
beginning of the culture period and stayed stable 
during the first 28 d; then, it significantly decreased 
to levels comparable to the other two cell types. 
These differences in cell numbers among groups at 
the beginning of culture could possibly be attributed 
to cell-loading inconsistencies. Nevertheless, dsDNA 
content among groups appeared to equalize over 
time (Fig. 4a).
 The synthesis of neocartilage matrix was evaluated 
by the amount of sulfated GAGs present in the 
hydrogel samples. Over the course of chondrogenic 
culture, AuCHs, AuCPCs and MSCs produced 
significantly increasing amounts of sGAG, which 
were retained in the hydrogel matrix. AuCHs and 
AuCPCs showed similar trends in total sGAG 
content (Fig. 4b) as well as in sGAG normalized 
to dsDNA content (Fig. 4c). After 56 d of culture, 
total sGAG content in AuCHs was 409.9 ± 35.7 μg/
mg and in AuCPCs 458.4 ± 30.9 μg/mg; sGAG/
dsDNA was 509.9 ± 56.8 μg/mg and 565.2 ± 40.8 μg/
mg, respectively. MSCs initially appeared to lag 
behind in total sGAG content (214.5 ± 25.1 μg/
mg at day 28, compared to 292.7 ± 29.5 μg/mg for 
AuCHs and 308.3 ± 15.8 μg/mg for AuCPCs), yet 
encompassed lower cell numbers in the samples. 
Accordingly, when normalized to dsDNA content, 
AuCHs, AuCPCs and MSCs performed similarly 
at the 28-d time point (304.9 ± 42.6, 329.7 ± 19.9 
and 296.9 ± 38.1 μg/mg, respectively). However, 
after 56 d of culture, when dsDNA levels were 
equivalent among groups, MSCs (789.5 ± 95.4 μg/mg) 
significantly outperformed both cartilage-derived 
cell types, displaying sGAG/dsDNA values 1.6-fold 
higher than AuCHs (508.9 ± 56.8 μg/mg) and 1.4-fold 
higher than AuCPCs (565.2 ± 40.8 μg/mg).
Mechanical properties of cell-laden hydrogels 
increased over time
Compressive mechanical testing was performed to 
evaluate the progressive changes in the stiffness 
of the constructs over time (Fig. 5). After 28 d of 
chondrogenic culture, the compressive Young’s 
Fig. 4. Quantification of (a) sulfated GAG content and (b) dsDNA content in cell-laden hydrogels after 
28 and 56 d of chondrogenic culture, both normalized against dry weight. The sGAG per dsDNA ratio is 
shown in c.Statistically significant differences of p < 0.05 for comparisons between cell types are marked 
with *. For each cell type, statistically significant differences of p < 0.05 are marked with ᵃ for a significant 
difference to day 1 and ᵇ for a significant difference to day 56. 
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modulus of AuCHs (41.3 ± 3.0 kPa) and MSCs 
(44.9 ± 5.6 kPa) increased non-significantly of 1.6-fold 
and 1.8-fold, respectively, in comparison to cell-free 
samples. Both cell types were outperformed by 
AuCPCs (83.2 ± 8.1 kPa), which exhibited a significant 
3.3-fold increase. When comparing these results to the 
total sGAG contents per sample, a 1.4-fold difference 
between AuCPCs and MSCs was noted; however, 
the observed difference in mechanical properties 
between AuCPCs and AuCHs was not reflected in 
total sGAG content.
 At the end of the culture period, MSCs 
(179.2 ± 22.2 kPa) significantly outperformed both 
AuCHs (102.8 ± 10.2 kPa) and AuCPCs (108.6 ± 10.1 kPa) 
in terms of compressive Young’s modulus (1.7-fold 
and 1.6-fold difference, respectively), correlating with 
the observed trends in total sGAG and sGAG/dsDNA 
content. In comparison with cell-free hydrogels, cell-
laden constructs demonstrated a significant increase 
in the compressive modulus of 10.5-fold for MSCs, 
6.4-fold for AuCPCs and 6.1-fold for AuCHs.
 The compressive Young’s modulus of cell-free 
constructs remained in the range of 16-25 kPa at 
all time points, indicating no notable degradation 
of the bulk properties of the hydrogel during the 
period of in vitro culture. In general, cartilage matrix 
synthesis in cell-laden hydrogels, as indicated by the 
total sGAG content, correlated with an increase in 
mechanical properties of the samples.
Histology and immunohistochemistry confirm 
matrix deposition
Histological sections displayed the presence and 
distribution of several main components of cartilage 
extracellular matrix in the hydrogel, including 
proteoglycans as well as collagen type II, I and VI 
(Fig. 6).
 Au C H s ,  Au C P C s  a n d  M S C s  s h o w e d 
inhomogeneous distribution of synthesized 
proteoglycans throughout the hydrogel constructs 
(Fig. 6a-c), with a gradation of decreasing labeling 
from the pericellular territorial to inter-territorial 
matrices. In all cases, there was an evident increase in 
the intensity of safranin O staining for proteoglycans 
over time. In line with the trends in total sGAG content, 
MSCs qualitatively displayed less proteoglycans at 
28 d of culture, yet exhibited the most intense staining 
at the end of the culture period in comparison to 
AuCPCs and to a greater extent to AuCHs. In all 
experimental groups, the deposition of collagen type 
II and type I seemed to occur predominantly in the 
outer rim of the cylindrical hydrogel constructs, with 
a lighter staining in the center. The diameter of this 
outer rim appeared to widen over time, indicating 
increased matrix deposition towards the center of 
the construct. MSCs and AuCPCs exhibited a more 
homogeneous distribution of collagen type II, whereas 
AuCHs displayed clusters of intense pericellular 
labeling (Fig. 6d-f). A similar trend was noted for 
collagen type I (Fig. 6g-i), where rims with the highest 
intensity staining were found in AuCH samples, 
followed by MSCs and AuCPCs. These observations 
correlated with COL1A1 mRNA expression profiles 
at day 56. Collagen type VI-labelled clusters (Fig. 6j-
l) were observed pericellularly after 56 d of culture 
in AuCPCs and to a lesser extent in MSCs, with only 
sporadic staining in AuCHs. Finally, von Kossa 
staining for mineralization did not show any black 
staining indicative of calcium in either group (Fig. 
6m-o).
Discussion
Cell selection for the generation of clinically relevant-
size cartilage tissue constructs remains a notable 
challenge in tissue engineering strategies. Cartilage-
derived progenitor cells represent a promising cell 
source for use in tissue engineering-based clinical 
therapies, since they can generate large numbers of 
cells while maintaining chondrogenic differentiation 
potential (Williams et al., 2010). In this study, 
progenitor cells originating from auricular cartilage 
demonstrated cartilage formation capacity in a 3D 
hydrogel system by generating a cartilage-like matrix 
in vitro.
 Traditionally, chondrocytes from various cartilage 
tissues (auricular, articular, costal and nasoseptal) are 
predominantly used for the engineering of auricular 
structures. Autologous cells have the greatest clinical 
potential in view of infectious considerations and 
adverse immunological response (Saadeh et al., 
1999). Nevertheless, the acquisition of a sufficient 
number of cells remains an important limitation 
in current tissue engineering approaches, since 
extensive expansion is required to obtain sufficient 
numbers of autologous cells for the creation of a 
large tissue constructs (Bichara et al., 2012). After 
only few population doublings in vitro, auricular, 
articular, septal and costal chondrocytes undergo 
Fig. 5. Compressive Young’s modulus of cell-laden 
hydrogels after 28 and 56 d of culture as compared 
to cell-free samples. Statistically significant 
differences of p < 0.05 for comparisons between 
cell types are marked with *. For each cell type, 
statistically significant differences of p < 0.05 are 
marked with ᵃ  for a significant difference to day 1 
and ᵇ for a significant difference to day 56. 
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dedifferentiation and lose their capacity to produce 
cartilage-specific glycosaminoglycans and collagens 
(Chung et al., 2006; Schulze-Tanzil et al., 2004; 
Schnabel et al., 2002; Homicz et al., 2002; Lee et al., 
2007; Nabzdyk et al., 2009; Williams et al., 2010). 
Although some studies demonstrate cartilage-
like tissue formation using extensively expanded 
chondrocytes, these dedifferentiated cells required 
the addition of fresh chondrocytes in order to salvage 
some of the chondrogenic phenotype characteristics 
(Pomerantseva et al., 2016; Tseng et al., 2014). Hence, 
primary chondrocytes seem less suitable as a single 
donor source for cartilage tissue engineering of large 
constructs, yet they may be beneficial additions to co-
cultures (Kang et al., 2012; Lv et al., 2012; Pleumeekers 
et al., 2015).
 MSCs are also successfully applied for the 
generation of cartilage-like tissue constructs (Cheng et 
al., 2014; Pleumeekers et al., 2013; Seda Tigli et al., 2009; 
Vinardell et al., 2012). MSCs are attractive for cartilage 
tissue engineering as they are harvested from the 
bone marrow with minimally invasive procedures, 
can be expanded to yield high cell numbers without 
losing their tissue-specific phenotype (Gardner 
et al., 2013) and have multipotent differentiation 
ability (Pittenger et al., 1999). In 3D culture, MSCs 
can be directed towards the chondrogenic lineage 
and are consequently applied in numerous studies 
for the generation of cartilage (Cheng et al., 2014; 
Pleumeekers et al., 2013; Seda Tigli et al., 2009; 
Vinardell et al., 2012). In fact, their usage is already 
being explored in clinical trials such as NCT02037204 
(IMPACT), NCT00885729 and NCT01227694 (as 
registered on clinicaltrials.gov). Nevertheless, the 
usage of MSCs for cartilage engineering harbors the 
risk of terminal differentiation of cells and subsequent 
calcification and ossification of tissues (Williams et al., 
2010). This results in calcification of the extracellular 
matrix (Gawlitta et al., 2010) – a phenomenon that 
is also observed in the costal cartilage framework 
implanted during auricular reconstruction surgery – 
causing an increasingly rigid construct (Jessop et al., 
2016). This is an unfavorable outcome for engineered 
auricular tissue structures as elasticity is one of the 
key features of the external ear (Nimeskern et al., 
2015b; Pappa et al., 2013; Xu et al., 2005).
 Tissue-specific progenitor cells maintain stem-
cell-like proliferative potential, yet also display 
tissue-specific phenotypes since they are harvested 
directly from the target tissue. In vivo, environmental 
influences from their niche prime progenitors to 
regulate proliferation and differentiation towards 
the target tissue, providing a clear advantage 
over non-tissue-specific stem-cells-like MSCs. 
Their proliferative ability addresses the important 
limitation in cell number acquisition that continues 
Fig. 6. Histological analysis of cell-laden hydrogels after 28 and 56 d in chondrogenic culture. Safranin 
O staining visualizing proteoglycan deposition in (a) AuCH, (b) AuCPC (c) and MSC samples, as well as 
immunohistochemistry for (d,e,f) collagen type II, (g,h,i) collagen type I and (j,k,l) collagen type VI. (m,n,o) 
Von Kossa staining demonstrating the absence of mineralization in all three cell types. Scale bars: 150 μm.
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to hamper the translation of large tissue-engineered 
constructs to clinical application. Cartilage stem/
progenitor cells were first identified in the superficial 
zone of the articular cartilage of the knee (Dowthwaite 
et al., 2004); yet, conclusive definitions on the identity 
of these cells remain elusive (Jiang and Tuan, 2015). 
Nevertheless, it is clear that cartilage tissue harbors 
a potent subpopulation of cells with distinct abilities 
from primary chondrocytes and a similar nature 
to MSCs. The current work presented the first 
identification and evaluation of this subpopulation 
of progenitor cells in equine auricular cartilage tissue 
and their potential for cartilage tissue engineering 
approaches.
 Previous literature reporting progenitor cells 
from auricular tissue is principally focused on cells 
originating from the perichondrial layer (Kobayashi 
et al., 2011a; Kobayashi et al., 2011b; Togo et al., 2006), 
which is a fibrous connective tissue consisting of 
fibroblasts and perichondrocytes. Recently, the 
first demonstration of the presence of an auricular 
cartilage progenitor population separated from the 
perichondrium has been presented by Xue et al. (2016) 
in a porcine species. The proliferation rate of these 
auricular cartilage stem/progenitor cells (CSPCs) is 
comparable to bone marrow-derived MSCs (Xue 
et al., 2016). Although the authors report a higher 
proliferation rate for perichondrium stem/progenitor 
cells (PSPCs), chondrogenic differentiation potential 
is greater for auricular cartilage stem/progenitor 
cells (Xue et al., 2016). PSPCs can differentiate 
into chondrocytes, yet maintaining a fibroblastic 
morphology (Kobayashi et al., 2011a; Xue et al., 2016). 
Cells derived from the cartilage tissue appear more 
apt to differentiate towards the chondrogenic and 
osteogenic lineages, whereas perichondrium-derived 
progenitor cells are inclined towards adipogenic 
differentiation (Xue et al., 2016). The cartilage-
forming potential of cartilage stem/progenitor cells 
has not yet been explored in 3D biomaterial culture 
for tissue engineering purposes. Hence, the present 
study focused on the use of cartilage progenitor cells, 
derived from the cartilage after complete removal 
of the perichondrium, for elastic cartilage tissue 
engineering. Besides fundamental characterization 
of these putative cartilage progenitor cells, their 
potential for cartilage regeneration for future 
therapeutic applications is of major interest.
 The results from the characterization of AuCPCs 
demonstrated that they had a behavior similar to 
MSCs in terms of multipotency. Similar to MSCs, 
AuCPCs had the ability to differentiate towards 
multiple lineages, as confirmed by positive stainings 
for bone, adipose tissue and cartilage. Furthermore, 
AuCPCs, being CD73+, CD90+, CD105+, CD34− and 
CD45−, displayed a gene expression profile for surface 
markers that is consistent with the minimal criteria 
for human MSCs (Dominici et al., 2006). Additional 
cell surface marker analysis showed similar gene 
expression profiles between AuCPCs and bone 
marrow-derived MSCs. A main difference among 
AuCHs, AuCPCs and MSCs arose in the expression 
of CD13, which is a marker widely expressed by a 
variety of cell subpopulations, including stem cells 
(Calloni et al., 2013; Dondossola et al., 2013). These 
data, in addition to the ability to differentiate towards 
multiple lineages, demonstrated a behavior similar 
to bone marrow-derived MSCs, both genetically and 
functionally.
 The limited knowledge on AuCPCs demands 
further investigation into specific cell characteristics, 
yet our study focused on advancing towards the 
utilization of these cells. Their stem cell characteristics, 
in addition to a differentiation capacity likely primed 
towards their source tissue, makes AuCPCs a highly 
interesting cell source for cartilage tissue engineering 
strategies. These cells provide an opportunity to 
overcome the drawbacks of the cell types currently 
used in cartilage tissue engineering and, thereby, can 
increase the likelihood of using tissue-engineered 
auricular cartilage structures for clinical application. 
Hence, the behavior of AuCPCs in 3D culture for 
tissue regeneration was explored in comparison to 
AuCHs and MSCs. Growth and differentiation in 
the 3D provides a more natural environment for 
cells and allows the preservation of tissue-specific 
characteristics (Pampaloni et al., 2007). In this study, 
cells were encapsulated in a 3D hydrogel system 
(gelMA) proven to be a permissive environment for 
neocartilage production (Klotz et al., 2016; Levato 
et al., 2017; Levett et al., 2013; Schuurman et al., 
2013). GelMA is a widespread platform for tissue 
engineering and bioprinting applications, owing to 
its natural bioactivity and tailorability (Klotz et al., 
2016). This versatile hydrogel can be functionalized 
for improved performance in supporting cells [for 
instance with hyaluronic acid (Levett et al., 2013)], 
printing resolution [e.g. with gellan gum (Mouser et 
al., 2016)] or mechanical stability [by incorporating 
reinforcing fibers (Visser et al., 2015), scaffolding 
materials, such as stiff and elastic hydrogels (Melchels 
and Blokzijl et al., 2016), or thermoplastic polymers 
(Mouser et al., 2017)]. Its biocompatibility and clinical 
grade options make gelMA a beneficial biomaterial 
choice with respect to future clinical translation (Klotz 
et al., 2016).
 In 3D hydrogel culture, all three cell types 
demonstrated increasing extracellular matrix 
production over the culture period, as indicated 
by sGAG/dsDNA quantification and confirmed by 
histology. Whereas AuCHs and AuCPCs displayed 
a similar matrix-synthesizing behavior, MSCs 
outperformed both cell types in terms of sGAG 
deposition. Proteoglycan aggregates are the major 
structural matrix components contributing to the 
mechanical properties of the tissue and the trend in 
matrix synthesis clearly matched the compressive 
moduli among cell types at the end of the culture 
period. Nevertheless, the observed differences in total 
sGAG content at 28 d of culture did not reflect the 
concurrent mechanical properties. At this time point, 
AuCPCs were outperforming MSCs in terms of total 
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sGAG content and compressive Young’s modulus, 
but the marked difference in Young’s modulus 
between AuCPCs and AuCHs was not observed in the 
total sGAG content. Since the mechanical properties 
of cartilage tissue are impacted by the organization 
of the tissue (Wu and Herzog, 2002), a potential 
explanation is a more homogeneous distribution 
of proteoglycans and collagens in both AuCPCs 
and MSCs upon histological examination, whereas 
AuCHs displayed a more cluster-like organization 
of matrix components. In our study, the mechanical 
properties of tissue-engineered cartilage constructs 
ranged between 102.8 and 179.2 kPa, which was 
at least a factor 10 inferior to native auricular 
cartilage. Griffin et al. (2016) report the compressive 
moduli of native human auricular cartilage to range 
between 1.41 and 2.08 MPa, whereas Nimeskern et 
al. (2015a) determine an instantaneous modulus of 
3.27-11.02 MPa, a maximum stress of 0.87-3.11 MPa 
and an equilibrium modulus of 2.22-7.23 MPa. 
Thus, tissue-engineered cartilage constructs require 
improved mechanical properties, which can be 
attained through supporting frameworks (Cervantes 
et al., 2013), by fiber reinforcement (Visser et al., 
2015) or possibly through mechanical loading of the 
developing neo-tissue, which is shown to increase 
cellular production of matrix components in articular 
cartilage (Musumeci, 2016).
 Differential mRNA expression of cartilage-specific 
markers confirmed cell differentiation towards the 
chondrogenic lineage in all three cell types. Although 
collagen type II expression was highly upregulated 
over the 56-d culture period, all three cell types 
demonstrated concurrent collagen type I expression, 
confirmed by immunohistochemistry. Improvement 
of neocartilage quality may be attained through 
functionalization of the hydrogel or by optimizing the 
recipe of the differential culture media. For example, 
the incorporation of hyaluronic acid in gelMA is 
shown to decrease collagen type I production (Levett 
et al., 2013), whereas supplementation with insulin-
like growth factor-1 (IGF-1) enhances the generation 
of elastic fibers in addition to improved overall tissue 
formation (Rosa et al., 2014).
 The auricle is a strong, yet flexible structure 
composed of cartilage of the elastic type. Its 
composition is similar to that of hyaline cartilage, 
consisting of negatively charged proteoglycan 
aggregates attracting water and a dense collagen 
type II network (Nabzdyk et al., 2009). Nevertheless, 
the auricular cartilage is unique in that it harbors 
an intricate network of elastic fibers. Elastin has a 
defining role in the mechanical properties of elastic 
cartilage, allowing flexibility and a swift return to its 
original shape after minor loads (Nimeskern et al., 
2015b). AuCPCs exhibited an upregulated expression 
of elastin in the cell-laden hydrogels. This feature 
offers the potential prime advantage of using AuCPCs 
over MSCs for tissue engineering of auricular 
cartilage, since the latter did not display elastin 
upregulation. Quantification and/or visualization 
of the production of elastin in tissue-engineered 
constructs could confirm this potential and would 
be advisable for future studies.
 One common problem with cartilage tissue 
engineering is calcification of the neo-tissue (Jessop 
et al., 2016). Primary chondrocytes may terminally 
differentiate and become hypertrophic, which can 
lead to calcification and eventually ossification of 
the neo-tissue (Gerstenfeld and Shapiro, 1996; Phull 
et al., 2016). Collagen type X is a typical marker 
of chondrocyte hypertrophy (Martin et al., 2001), 
although its presence is demonstrated in native 
non-mineralized auricular cartilage (Dahl et al., 
2011; Hellingman et al., 2011). Several studies report 
the expression of collagen type X in cartilage tissue 
engineered from auricular chondrocytes, yet this 
does not result in mineralization of neo-tissues in 
both in vitro and in vivo conditions (Dahl et al., 2011; 
Hellingman et al., 2011). Indeed, in this study, the 
mRNA expression of collagen type X was highly 
upregulated in AuCHs, indicating chondrocyte 
hypertrophy. Nonetheless, our findings confirmed 
that this did not result in mineralization of the neo-
tissue up to 56 d of in vitro culture. The relatively 
low expression of COL10A1 in both AuCPCs and 
MSCs might indicate preservation of the phenotype 
in these cell types under in vitro chondrogenic 
conditions. Nevertheless, the expression of RUNX2 
was significantly upregulated in MSCs as compared 
to AuCPCs and AuCHs at 56 d of culture. RUNX2 
drives osteogenic differentiation and inhibits 
differentiation of MSCs into chondrocytes (Komori, 
2006). In contrast, AuCPCs demonstrated a significant 
reduction in RUNX2 expression over time. MSCs 
from the bone marrow form bone in vivo through 
the endochondral ossification pathway (Gawlitta 
et al., 2010), whereas AuCPCs originate from the 
cartilage itself and their niche may have primed 
them towards the target tissue, maintaining their 
specific phenotype. The lack of hypertrophy in 
AuCPC cultures, as well as the decreased RUNX2 and 
increased elastin expression levels pointed to a stable 
phenotype that is amenable for tissue engineering.
 In conclusion, the identification of a cartilage 
progenitor subpopulation in the auricular cartilage 
provided access to a promising cell source for tissue 
engineering strategies for auricular reconstruction. 
Although under the current culturing conditions, 
bone marrow-derived MSCs seemed to perform better 
in terms of matrix production, major advantages of 
AuCPCs include the ability to generate high cell 
numbers (Williams et al., 2010; Xue et al., 2016), 
upregulation of the elastin gene and a limited 
endochondral ossification potential. Taken together, 
these advantages make progenitor cells from the 
auricular cartilage a highly interesting candidate 
as a cell source for future tissue-engineering-based 
clinical therapies.
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Discussion with Reviewers
Oliver Gardner: Articular cartilage progenitor cells 
have a highly specific location within the tissue, which 
relates to their role in the growth and maintenance of 
the tissue. Do the authors believe that AuCPCs have 
a specific niche and role within auricular cartilage?
Authors: For auricular cartilage progenitor cells there 
is currently no proof of a specific localization, also due 
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to the limited amount of studies focusing on these 
cells. Since there is a lack of specific markers for these 
cells, such a localization cannot yet be easily defined. 
As it may be possible that AuCPCs have a specific 
niche within the auricular cartilage, future studies 
on the developmental origin, exact tissue localization 
and role of AuCPCs would be very interesting for the 
field of cartilage biology.
Karoliina Pelttari: Can a big enough biopsy 
be harvested from patients without donor site 
morbidity? What about patients with bilateral 
microtia?
Authors: Cartilage progenitor cells are thought 
to form up to ± 0.7 % of the cell population in the 
articular cartilage and are reported to be able to 
proliferate to over 60 population doublings (Williams 
et al., 2010). Similar characteristics in progenitors 
from other cartilage sources are expected. AuCPCs 
demonstrated a potent ability to proliferate up to 
passage 4 – when, in the present study, the cells 
were utilized for tissue engineering purposes – 
meaning that large amounts of functional cells can 
be generated. Although exact calculations on the 
number of progenitor cells obtainable from a specific 
cartilage volume are outside the scope of this study, 
the proliferation potential of progenitor cells suggest 
that, with only a small biopsy from the auricular 
cartilage, a sufficient number of cells can be generated 
for the production of a full-sized tissue-engineered 
auricle. Cells can be obtained from healthy auricular 
cartilage or from the microtia remnant, although the 
presence of progenitor cells in the latter tissue has 
not yet been reported. Depending on the proliferative 
and cartilage-forming ability of microtia-derived 
cells, this source can potentially overcome donor site 
morbidity in both unilateral and bilateral microtia 
patients.
Karoliina Pelttari: Are cells from patients with 
congenital microtia different from healthy auricular 
chondrocyte? Gu et al. (2017) (additional reference) 
show an inferior cartilage-forming capacity of 
microtia-chondrocytes.
Authors: The microtic auricle is a congenital 
deformity. Its etiology is not fully understood, yet 
there is evidence for the involvement of environmental 
factors besides genetic factors (Luquetti et al., 2012, 
additional reference). On a macroscopic level, the 
microtic cartilage is reported to possess similar cell 
morphology and tissue organization (Melgarejo-
Ramirez et al., 2016, additional reference). Various 
studies observed no marked differences between 
healthy and microtia chondrocytes in terms of growth 
rates, expression of cartilage genes and ability to 
generate cartilage-like tissue in vivo (Kamil et al., 
2004; Ishak et al., 2011, additional reference; Ishak 
et al., 2015; Nakao et al., 2017). Indeed, Gu et al. 
(2017) report a biochemically and biomechanically 
inferior quality neocartilage produced by microtia 
chondrocytes. These contrasting results indicate the 
need for a further exploration of differences between 
microtia and healthy chondrocytes and their ability 
for cartilage production under various conditions.
Karoliina Pelttari: Have such AuCPC with similar 
characteristics been identified in human?
Authors: Cartilage progenitor cells are a relatively 
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